We bring rigorous experience in health economics methodology to the complexities of health care litigation and policy analysis. Led by Director Cara Scheibling and CEO John Schneider, PhD, our in-house experts and consultants have extensive knowledge and experience providing health economics analysis, epidemiology, and marketing and analytics advice and testimony in support of a wide range of healthcare litigation and policy applications. We are extremely knowledgeable in data sources, health insurance claims, and patient medical records.
Our expansive knowledge and experience in HEOR analytics, statistical analyses of data, syntheses of medical and economic literature, and simulation modelling add value to our litigation work. Our specific areas of expertise are listed below, and include substantial depth in a wide range of litigation, regulatory, and policy areas.
In health-related litigation, it is often necessary to determine “reasonable value,” which is akin to “fair market value” in economics and, unlike list prices, is not distorted by mark-ups and discounts. Watch our video to learn how we apply this in cases:
The Economics of Reasonable Value and the Valuation of Medical Losses. 2019
What is the Reasonable Value of Future Medical Care? 2019
Evaluation of Health in Pregnancy grants in Scotland: a natural experiment using routine data. 2017
Are financial incentives cost-effective to support smoking cessation during pregnancy? 2016
The progressivity of health-care financing in Kenya. 2014
Effects of health savings account-eligible plans on utilization and expenditures. 2011
Converting to critical access status: how does it affect rural hospitals’ financial performance? 2009
The economics of specialty hospitals. 2008
Effects of specialty hospitals on the financial performance of general hospitals, 1997-2004. 2007
Effect of critical access hospital conversion on patient safety. 2007
What would be the effect of referral to high-volume hospitals in a largely rural state? 2004
